What is the recommended dosage and treatment duration of Cipro (ciprofloxacin) for bacterial infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ciprofloxacin Dosage and Treatment Duration for Bacterial Infections

For bacterial infections, ciprofloxacin should be administered at 250-750 mg orally twice daily for 7-14 days for most infections, with specific dosages and durations based on infection type and severity. 1

Standard Adult Dosing Regimens

Oral Administration

  • Mild to Moderate Infections: 500 mg every 12 hours 1
  • Severe/Complicated Infections: 750 mg every 12 hours 1

Intravenous Administration

  • Severe Infections: 400 mg every 8-12 hours 2
  • IV to Oral Conversion:
    • 200 mg IV q12h = 250 mg oral q12h
    • 400 mg IV q12h = 500 mg oral q12h
    • 400 mg IV q8h = 750 mg oral q12h 1

Infection-Specific Dosing

Infection Type Severity Dose Frequency Duration
Lower Respiratory Tract Mild/Moderate 500 mg q12h 7-14 days
Lower Respiratory Tract Severe/Complicated 750 mg q12h 7-14 days
Urinary Tract Uncomplicated 250 mg q12h 3 days
Urinary Tract Complicated 500 mg q12h 7-14 days
Skin/Skin Structure Mild/Moderate 500 mg q12h 7-14 days
Skin/Skin Structure Severe/Complicated 750 mg q12h 7-14 days
Bone and Joint Mild/Moderate 500 mg q12h ≥4-6 weeks
Bone and Joint Severe/Complicated 750 mg q12h ≥4-6 weeks
Intra-Abdominal* Complicated 500 mg q12h 7-14 days
Infectious Diarrhea Mild/Moderate/Severe 500 mg q12h 5-7 days
Typhoid Fever Mild/Moderate 500 mg q12h 10 days
Chronic Bacterial Prostatitis Mild/Moderate 500 mg q12h 28 days
Acute Sinusitis Mild/Moderate 500 mg q12h 10 days
Gonococcal Infections Uncomplicated 250 mg Single dose Single dose
Inhalational Anthrax Post-exposure 500 mg q12h 60 days

*Used in conjunction with metronidazole 1

Pediatric Dosing

  • Children (≥1 month to ≤17 years): 10-15 mg/kg every 12 hours orally (not to exceed 1 g/day) 2
  • Intravenous: 10 mg/kg every 8 or 12 hours 2

Dosing in Renal Impairment

Creatinine Clearance Recommended Dose
>50 mL/min Standard dosage
30-50 mL/min 250-500 mg q12h
5-29 mL/min 250-500 mg q18h
Hemodialysis/Peritoneal dialysis 250-500 mg q24h (after dialysis)

1

Important Administration Guidelines

  1. Administer at least 2 hours before or 6 hours after:

    • Magnesium/aluminum antacids
    • Sucralfate
    • Products containing calcium, iron, or zinc 1
  2. Continue treatment for at least 2 days after signs and symptoms of infection have disappeared 1

Clinical Pearls and Pitfalls

  • Oral Bioavailability: Oral ciprofloxacin is rapidly and well absorbed with maximum serum concentrations attained 1-2 hours after dosing 2
  • Treatment Duration: Inadequate duration can lead to relapse; continue for at least 2 days after clinical improvement 1
  • Special Populations:
    • Pregnancy: Not recommended during pregnancy unless benefits outweigh risks for life-threatening infections 3
    • Children: Use only when benefits outweigh risks due to potential effects on developing joints/cartilage 2
  • Resistance Prevention: Inadequate dosing may lead to treatment failure and promote antimicrobial resistance 2

Evidence Quality Assessment

The FDA drug label 1 and CDC guidelines 2 provide the most authoritative and recent recommendations for ciprofloxacin dosing. These guidelines are consistent with clinical trial data showing efficacy of standard twice-daily dosing for most infections, with duration tailored to infection type and severity.

References

Guideline

Ciprofloxacin Dosage Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.